BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 33454822)

  • 1. DNA methyltransferase- and histone deacetylase-mediated epigenetic alterations induced by low-level methylmercury exposure disrupt neuronal development.
    Go S; Kurita H; Hatano M; Matsumoto K; Nogawa H; Fujimura M; Inden M; Hozumi I
    Arch Toxicol; 2021 Apr; 95(4):1227-1239. PubMed ID: 33454822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methylmercury causes epigenetic suppression of the tyrosine hydroxylase gene in an in vitro neuronal differentiation model.
    Go S; Kurita H; Matsumoto K; Hatano M; Inden M; Hozumi I
    Biochem Biophys Res Commun; 2018 Aug; 502(4):435-441. PubMed ID: 29856999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exposure to a low concentration of methylmercury in neural differentiation downregulates NR4A1 expression with altered epigenetic modifications and inhibits neuronal spike activity in vitro.
    Go S; Masuda H; Tsuru M; Inden M; Hozumi I; Kurita H
    Toxicol Lett; 2023 Feb; 374():68-76. PubMed ID: 36565944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of methylmercury on epigenetic markers in three model species: mink, chicken and yellow perch.
    Basu N; Head J; Nam DH; Pilsner JR; Carvan MJ; Chan HM; Goetz FW; Murphy CA; Rouvinen-Watt K; Scheuhammer AM
    Comp Biochem Physiol C Toxicol Pharmacol; 2013 Apr; 157(3):322-7. PubMed ID: 23481557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inherited effects of low-dose exposure to methylmercury in neural stem cells.
    Bose R; Onishchenko N; Edoff K; Janson Lang AM; Ceccatelli S
    Toxicol Sci; 2012 Dec; 130(2):383-90. PubMed ID: 22918959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-lasting neurotoxic effects of exposure to methylmercury during development.
    Ceccatelli S; Bose R; Edoff K; Onishchenko N; Spulber S
    J Intern Med; 2013 May; 273(5):490-7. PubMed ID: 23600401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct monitoring of breast and endometrial cancer cell epigenetic response to DNA methyltransferase and histone deacetylase inhibitors.
    Teixeira SR; Abreu CM; Parkes L; Davies J; Yao S; Sawhney MA; Margarit L; Gonzalez D; Pinto IM; Francis LW; Conlan RS
    Biosens Bioelectron; 2019 Sep; 141():111386. PubMed ID: 31220725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic regulation of tumor endothelial cell anergy: silencing of intercellular adhesion molecule-1 by histone modifications.
    Hellebrekers DM; Castermans K; Viré E; Dings RP; Hoebers NT; Mayo KH; Oude Egbrink MG; Molema G; Fuks F; van Engeland M; Griffioen AW
    Cancer Res; 2006 Nov; 66(22):10770-7. PubMed ID: 17108113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetics of methylmercury.
    Cediel-Ulloa A; Lindner S; Rüegg J; Broberg K
    Neurotoxicology; 2023 Jul; 97():34-46. PubMed ID: 37164037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prenatal low-dose methylmercury exposure impairs neurite outgrowth and synaptic protein expression and suppresses TrkA pathway activity and eEF1A1 expression in the rat cerebellum.
    Fujimura M; Usuki F; Cheng J; Zhao W
    Toxicol Appl Pharmacol; 2016 May; 298():1-8. PubMed ID: 26965727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of buffalo (Bubalus bubalis) donor cells with trichostatin A and 5-aza-2'-deoxycytidine alters their growth characteristics, gene expression and epigenetic status and improves the in vitro developmental competence, quality and epigenetic status of cloned embryos.
    Saini M; Selokar NL; Agrawal H; Singla SK; Chauhan MS; Manik RS; Palta P
    Reprod Fertil Dev; 2016 Apr; 28(6):824-37. PubMed ID: 25409339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-lasting depression-like behavior and epigenetic changes of BDNF gene expression induced by perinatal exposure to methylmercury.
    Onishchenko N; Karpova N; Sabri F; Castrén E; Ceccatelli S
    J Neurochem; 2008 Aug; 106(3):1378-87. PubMed ID: 18485098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Epigenetic mechanisms and alcohol use disorders: a potential therapeutic target].
    Legastelois R; Jeanblanc J; Vilpoux C; Bourguet E; Naassila M
    Biol Aujourdhui; 2017; 211(1):83-91. PubMed ID: 28682229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetics and Methylmercury-Induced Neurotoxicity, Evidence from Experimental Studies.
    Ke T; Tinkov AA; Skalny AV; Santamaria A; Rocha JBT; Bowman AB; Chen W; Aschner M
    Toxics; 2023 Jan; 11(1):. PubMed ID: 36668798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic Regulatory Mechanisms Induced by Resveratrol.
    Fernandes GFS; Silva GDB; Pavan AR; Chiba DE; Chin CM; Dos Santos JL
    Nutrients; 2017 Nov; 9(11):. PubMed ID: 29104258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pregnant rats exposed to low-level methylmercury exhibit cerebellar synaptic and neuritic remodeling during the perinatal period.
    Fujimura M; Usuki F
    Arch Toxicol; 2020 Apr; 94(4):1335-1347. PubMed ID: 32140736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of prenatal Poly I:C exposure on global histone deacetylase (HDAC) and DNA methyltransferase (DNMT) activity in the mouse brain.
    Pujol Lopez Y; Kenis G; Stettinger W; Neumeier K; de Jonge S; Steinbusch HW; Zill P; van den Hove DL; Myint AM
    Mol Biol Rep; 2016 Jul; 43(7):711-7. PubMed ID: 27216537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic therapy in cancer: molecular background and clinical development of histone deacetylase and DNA methyltransferase inhibitors.
    Schneider-Stock R; Ocker M
    IDrugs; 2007 Aug; 10(8):557-61. PubMed ID: 17665331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impacts of TCDD and MeHg on DNA methylation in zebrafish (Danio rerio) across two generations.
    Olsvik PA; Williams TD; Tung HS; Mirbahai L; Sanden M; Skjaerven KH; Ellingsen S
    Comp Biochem Physiol C Toxicol Pharmacol; 2014 Sep; 165():17-27. PubMed ID: 24878852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of cardiovascular pathology with epigenetically active agents: Focus on natural and synthetic inhibitors of DNA methylation and histone deacetylation.
    Chistiakov DA; Orekhov AN; Bobryshev YV
    Int J Cardiol; 2017 Jan; 227():66-82. PubMed ID: 27852009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.